This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents. Top assignees: Chaperone Therapeutics, Inc., Duke University. Active years: 2015-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2015-2017
Title: The Innovations of Daniel W Neef
Introduction
Daniel W Neef is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that activate heat shock transcription factors. With a total of 5 patents to his name, Neef's work has implications for various therapeutic applications.
Latest Patents
One of Neef's latest patents is focused on "Substituted pyrazoles as heat shock transcription factor activators." This invention relates to HSF activating compounds, methods for their discovery, and their research and therapeutic uses. It also includes pharmaceutically acceptable salts, solvates, chelates, non-covalent complexes, prodrugs, and pharmaceutical formulations. The invention provides compounds capable of facilitating HSF1 homotrimerization and methods for using these compounds as therapeutic agents to treat conditions associated with irregular HSF1 activity.
Career Highlights
Throughout his career, Daniel W Neef has worked with esteemed institutions such as Duke University and Chaperone Therapeutics, Inc. His research has focused on innovative solutions in the pharmaceutical industry, contributing to advancements in medical treatments.
Collaborations
Neef has collaborated with notable colleagues, including Dennis J Thiele and Jose Mendoza. These partnerships have further enriched his research and development efforts in the field.
Conclusion
Daniel W Neef's contributions to the field of pharmaceutical sciences through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to influence therapeutic approaches in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile